Stage II Prostate Cancer: Clinical Trials

21 trials for Stage II Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 7 Not applicable, 7 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 4, Recruiting 2, Not yet recruiting 1
Phase 27Completed 4, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 13Completed 3
Phase 32Completed 1, Terminated 1

Follow Stage II Prostate Cancer: new trials by email Literature Review of Stage II Prostate Cancer trials Research Report on Stage II Prostate Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Researching the Effect of Exercise on Cancer
Exercise - Breast Cancer, Prostate Cancer
Not applicableRecruitingCity of Hope Medical Center512026-10-302026-08-27
Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
MINDSET, Enhanced Usual Care (EUC) - Depression, Cancer
Not applicableNot yet recruitingCase Comprehensive Cancer Center762026-08-032026-01-23
Ask Questions (ASQ):Implementation of a Communication Intervention
Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer
Not applicableCompletedBarbara Ann Karmanos Cancer Institute812021-08-252023-08-16
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
Interview, Questionnaire Administration - Prostate Adenocarcinoma, Stage I Prostate Cancer
CompletedWake Forest University Health Sciences2552019-07-192025-07-16
Acupuncture Pilot Study for Cancer-related Cognitive Function
Acupuncture, Sham Acupuncture, 16 week waiting period + optional Acupuncture - Stage I Breast Cancer, Stage II Breast Cancer
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center482019-07-012026-08-12
Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer
Dietary Intervention, Educational Intervention, Exercise Intervention - Cancer Survivor, Obesity
Not applicableRecruitingRoswell Park Cancer Institute502019-05-022026-05-07
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
Internet-Based Intervention, Best Practice, Quality-of-Life Assessment - Stage II Prostate Cancer, Stage IIA Prostate Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology1582017-10-022025-01-27
Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer
Biospecimen Collection, Laboratory Biomarker Analysis, Questionnaire Administration - Hormone-Resistant Prostate Cancer, Recurrent Prostate Carcinoma
CompletedWake Forest University Health Sciences612017-02-222022-03-10
Visually Enhanced Education About Prostate Cancer
Visually enhanced prostate cancer educational presentation, Standard prostate cancer education presentation - Stage I Prostate Cancer, Stage II Prostate Cancer
Not applicableCompletedVanderbilt-Ingram Cancer Center302016-09-012020-07-23
Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer
Informational Intervention, Internet-Based Intervention, Quality-of-Life Assessment - Stage I Breast Cancer, Stage I Colorectal Cancer AJCC v6 and v7
Not applicableCompletedRutgers, The State University of New Jersey5352013-09-032022-08-29
Genistein in Treating Patients With Prostate Cancer
genistein, placebo, therapeutic conventional surgery - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer
Phase 2TerminatedNorthwestern University122011-02-032019-09-10
Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer
intensity modulated external beam radiation therapy - Adenocarcinoma of the Prostate, Stage I Prostate Cancer
Not applicableCompletedVirginia Commonwealth University552010-05-302019-06-28
Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer
abiraterone acetate, prednisone, leuprolide acetate - Adenocarcinoma of the Prostate, Stage II Prostate Cancer
Phase 2CompletedUniversity of Washington242010-03-012017-06-06
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate
radiation therapy treatment planning/simulation, intensity-modulated radiation therapy, image-guided radiation therapy - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 1CompletedAbramson Cancer Center at Penn Medicine102009-06-012019-07-25
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate
Docetaxel, Prednisone - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 2WithdrawnJohn P. Fruehauf2009-01-012016-12-08
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer
placebo, therapeutic conventional surgery, laboratory biomarker analysis - Adenocarcinoma of the Prostate, Stage I Prostate Cancer
Phase 2CompletedNational Cancer Institute (NCI)102008-02-012019-12-18
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
defined green tea catechin extract, placebo, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage I Prostate Cancer
Phase 1CompletedNational Cancer Institute (NCI)502007-03-012014-10-08
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
diindolylmethane, placebo, therapeutic conventional surgery - Adenocarcinoma of the Prostate, Prostate Cancer
Phase 1CompletedNational Cancer Institute (NCI)452007-02-012015-12-04
Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
Finasteride, Placebo, Prostatectomy - Adenocarcinoma of the Prostate, Stage II Prostate Cancer
Phase 2CompletedNational Cancer Institute (NCI)2042007-02-012016-03-09
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
sorafenib tosylate, microarray analysis, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage II Prostate Cancer
Phase 2CompletedUniversity of Washington52006-12-012017-11-22

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (21)  ·  Breast Neoplasms (5)  ·  Colorectal Neoplasms (5)  ·  Adenocarcinoma (1)  ·  Depression (1)  ·  Erectile Dysfunction (1)  ·  Kidney Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Motor Activity (1)  ·  Neoplasms (1)  ·  Obesity (1)  ·  Ovarian Neoplasms (1)  ·  Overweight (1)  ·  Urinary Bladder Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Genital Diseases (21)  ·  Genital Diseases, Male (21)  ·  Genital Neoplasms, Male (21)  ·  Male Urogenital Diseases (21)  ·  Neoplasms by Site (21)  ·  Prostatic Diseases (21)  ·  Urogenital Diseases (21)  ·  Urogenital Neoplasms (21)  ·  Neoplasms (20)  ·  Breast Diseases (5)  ·  Colonic Diseases (5)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)

Interventions

Immunohistochemistry (2)  ·  Prednisone (2)  ·  3,3'-diindolylmethane (1)  ·  Abiraterone Acetate (1)  ·  Acupuncture Therapy (1)  ·  Alprostadil (1)  ·  Behavior Therapy (1)  ·  Biopsy (1)  ·  Biopsy, Needle (1)  ·  Blotting, Western (1)  ·  Chromatography, High Pressure Liquid (1)  ·  Diet Therapy (1)  ·  Docetaxel (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  City of Hope Medical Center (2)  ·  University of Washington (2)  ·  Wake Forest University Health Sciences (2)  ·  Abramson Cancer Center at Penn Medicine (1)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Case Comprehensive Cancer Center (1)  ·  John P. Fruehauf (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Northwestern University (1)  ·  Roswell Park Cancer Institute (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Virginia Commonwealth University (1)

Countries

United States (20)  ·  Guam (1)

Top investigators

Austin Kirschner, MD (1)  ·  Bart Frizzell (1)  ·  Chelsea Siwik, PhD (1)  ·  Ellis Levine, MD (1)  ·  Evan Yu (1)  ·  Frederick Ahmann (1)  ·  Glenn Lesser, MD (1)  ·  James Eastham (1)  ·  Jason Gee (1)  ·  Jeri Kim (1)  ·  John P. Fruehauf, MD, PhD (1)  ·  Jun Mao, MD, MSCE (1)  ·  Laura Crocitto (1)  ·  Lee Jones, MD (1)  ·  Michael G. Chang, MD (1)

Results publications

PMID 22044694, PMID 30081846, PMID 30971205, PMID 32974208, PMID 34890060

NIH funding

N01CN35159 (2), P30CA012197 (2), P30CA016672 (2), N01CN35153 (1), N01CN35158 (1), P30CA015704 (1), P30CA033572 (1), P50CA090386 (1), R01CA176838 (1), UG1CA189824 (1)